Cite
HARVARD Citation
Green, M. et al. (2016). Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery. Journal of hematology & oncology. 9 (1), pp. 1-10. [Online].